CF Industries Holdings Inc(CF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CF CF Industries Holdings Inc

Not Yet Opened 03-26 16:00:00 EDT

76.64

+1.61

+2.15%

盘后76.75

+0.11+0.14%

19:59 EDT

High76.88	Low74.94	Vol2.48M
Open75.00	D1 Closing75.03	Amplitude2.59%
Mkt Cap12.99B	Tradable Cap12.87B	Total Shares169.54M
T/O189.18M	T/O Rate1.48%	Tradable Shares167.87M
P/B2.61	ROE18.50%	EPS6.74
52wk High98.25	52wk Low69.13	P/E11.37
Dividend2.00	Div.Yield0.03	ROA7.74%

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"CF","market":"US","secType":"STK","nameCN":"CF Industries Holdings Inc","latestPrice":76.64,"timestamp":1743019200000,"preClose":75.03,"halted":0,"volume":2481142,"hourTrading":{"tag":"盘后","latestPrice":76.75,"preClose":76.64,"latestTime":"19:59 EDT","volume":237070,"amount":18168144.0699,"timestamp":1743033546071},"delay":0,"floatShares":167867950,"shares":169536803,"eps":6.74,"marketStatus":"Not Yet Opened","change":1.61,"latestTime":"03-26 16:00:00 EDT","open":75,"high":76.88,"low":74.9382,"amount":189175366.50976,"amplitude":0.02588,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.74,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1743062400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1123732800000,"exchange":"NYSE","adjPreClose":75.03,"dividendRate":0.026096,"preHourTrading":{"tag":"盘前","latestPrice":75,"preClose":75.03,"latestTime":"09:21 EDT","volume":5869,"amount":438516.30322000006,"timestamp":1742995278133},"postHourTrading":{"tag":"盘后","latestPrice":76.75,"preClose":76.64,"latestTime":"19:59 EDT","volume":237070,"amount":18168144.0699,"timestamp":1743033546071},"volumeRatio":0.73238,"impliedVol":0.3841,"impliedVolPercentile":0.908},"requestUrl":"/m/hq/s/CF","defaultTab":"news","newsList":[{"id":"2522354878","title":"CF Industries Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2522354878","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522354878?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 05:16","pubTimestamp":1742937360,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of CF Industries Holdings Inc.  shed 2.34% to $75.03 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.16% to 5,776.65 and the Dow Jones Industrial Average  rising 0.01% to 42,587.50.CF Industries Holdings Inc. closed 23.63% below its 52-week high of $98.25, which the company reached on January 16th.The stock underperformed when compared to some of its competitors Tuesday, as Mosaic Co.  fell 1.63% to $27.18 and Westlake Corp.  fell 1.92% to $100.68.Trading volume  eclipsed its 50-day average volume of 2.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 25, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CF"],"gpt_icon":0},{"id":"2522047145","title":"BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2522047145","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522047145?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 18:30","pubTimestamp":1742898600,"startTime":"0","endTime":"0","summary":"In February 2025, BiomX announced a series of financings with total gross proceeds of approximately $12 million to support completion of Phase 2b study of BX004; topline results anticipated in Q1 2026. Topline Phase 2 results for BX211 in diabetic foot osteomyelitis  expected by end of March 2025. Initiated exploration and analysis of real-world evidence in people with Cystic Fibrosis  on the relationship between Pseudomonas aeruginosa reduction and clinical outcomes, ahead of expected regulatory discussions in second half of 2025. BX004 – fixed phage cocktail for the treatment of cystic fibrosis  in patients with chronic pulmonary infections caused byPseudomonas aeruginosa. Trial remains on track to report topline results in the first quarter of 2026. During the fourth quarter of 2024, BiomX encountered manufacturing delays relating to scaling up of materials for the larger phase 2 trial. These chal","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biomx-reports-fourth-quarter-full-103000362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CF","BK4568","BK4086","BK4588","BK4139","BK4585","APT","BK4093","PHGE"],"gpt_icon":0},{"id":"2521775717","title":"Here's Why You Should Hold Onto CF Industries Stock for Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2521775717","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521775717?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 21:10","pubTimestamp":1742821800,"startTime":"0","endTime":"0","summary":"CF Industries Holdings, Inc. CF is expected to benefit from higher nitrogen fertilizer demand in major markets and lower natural gas costs amid headwinds from soft nitrogen prices.The company’s shares are down 7.5% over a year compared with a 4.6% decline of its industry.CF is exposed to headwinds from weak nitrogen prices. Higher global supply availability driven by higher global operating rates due to lower global energy costs put pressure on nitrogen prices last year. CF’s average selling prices in 2024 were lower than in 2023 due to lower global energy costs, which reduced the global clearing price required to meet demand. It saw lower year-over-year prices across its segments in 2024. While the company is seeing improved prices lately, weaker year-over-year prices are expected to impact its results over the near term. Weak pricing is expecte","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-hold-onto-cf-131000250.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0031619046.USD","BK4588","CRS","BK4109","BK4093","BK4585","NGVT","AXTA","IE00B7SZL793.SGD","IE00B19Z4B17.USD","IE00B66KJ199.SGD","LU0006061336.USD","LU1074936037.SGD","LU2065731478.USD","CF","BK4561","BK4006"],"gpt_icon":0},{"id":"2521747311","title":"Scotiabank Keeps Their Sell Rating on Cf Industries Holdings (CF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2521747311","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521747311?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 19:45","pubTimestamp":1742816731,"startTime":"0","endTime":"0","summary":"Scotiabank analyst Ben Isaacson maintained a Sell rating on Cf Industries Holdings (CF – Research Report) today and set a price target of $81.00. T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/scotiabank-keeps-their-sell-rating-on-cf-industries-holdings-cf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/scotiabank-keeps-their-sell-rating-on-cf-industries-holdings-cf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CF"],"gpt_icon":0},{"id":"2521616228","title":"Houlihan Lokey (HLI): Among Stocks Wall Street Is Calling Bullish Amid Market Turmoil","url":"https://stock-news.laohu8.com/highlight/detail?id=2521616228","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521616228?lang=en_us&edition=full_marsco","pubTime":"2025-03-23 06:56","pubTimestamp":1742684182,"startTime":"0","endTime":"0","summary":"The S&P 500 is down 8.6% in a month while the Nasdaq has lost nearly 13%. Markets continue to scare retail investors as stock after stock struggles to deal with the aftermath of Donald Trump’s unpredictable and aggressive policies.While it is advisable to stay out of the market till the dust settles, one also can’t deny that it is times like these that bring opportunities. We decided to come up with a list of stocks that are expected to go up even in the existing gloomy environment.To come up with the list of 10 stocks that Wall Street is bullish on, we looked at stocks that were recently upgraded by analysts and have performed well in the last 5 days of trading.A close-up of hands shaking to signify a newly negotiated financial restructuring transaction.Houlihan Lokey  recently announced its Q3 financial results demonstrating a strong performance. As per the results, the company grew its revenue by 24% YoY accompanied by a 34% YoY increase in the adjusted EPS. On top of this solid per","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/houlihan-lokey-hli-among-stocks-225622668.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HLI","FR","BK4093","CF","BK4585","BK4224","IE00B19Z6F94.USD","BK4588","LU1878469433.USD","BK4171","BK4127"],"gpt_icon":0},{"id":"2521258101","title":"CF (CF) Down 4.2% Since Last Earnings Report: Can It Rebound?","url":"https://stock-news.laohu8.com/highlight/detail?id=2521258101","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521258101?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 23:30","pubTimestamp":1742571028,"startTime":"0","endTime":"0","summary":"A month has gone by since the last earnings report for CF Industries . Shares have lost about 4.2% in that time frame, outperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is CF due for a breakout?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.It turns out, estimates revision have trended upward during the past month.At this time, CF has a subpar Growth Score of D, however its Momentum Score is doing a lot better with an A. Following the exact same course, the stock was allocated a grade of A on the value side, putting it in the top 20% for this investment strategy.Estimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, CF has a Zacks Rank #3 . We expect an in-line return from the stock in the next few months.CF Industries H","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cf-cf-down-4-2-153028610.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CF"],"gpt_icon":0},{"id":"2520437381","title":"Press Release: Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2520437381","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520437381?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 19:00","pubTimestamp":1742468400,"startTime":"0","endTime":"0","summary":"Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide clinically meaningful benefit to CF patients. Topline data anticipated in first half of 2025. On track to initiate NBD1 Phase 2a proof-of-concept trial in combination with SOC in CF patients and combination MAD trials of an NBD1 stabilizer with a complementary modulator in healthy volunteers in the second half of 2025, with topline data for both anticipated in mid-2026. Completed upsized IPO with gross proceeds of approximately $219 million, extending runway into 2028","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","BK4139","BK4213","BK4218","BK4093","SION","BK4585","BK4588","PK","SOC","CF"],"gpt_icon":0},{"id":"2520156086","title":"Is Vertex Pharmaceuticals (VRTX) the Best Diabetes Stock to Buy According to Billionaires?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520156086","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520156086?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 22:16","pubTimestamp":1742393815,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated  stands against other best diabetes stocks to buy according to billionaires.The Growing Market and Innovation in Continuous Glucose Monitoring  Technology. The GlobalData marketed products database shows that there are currently 97 products in the CGM category. Most of these devices are standard CGMs, with only a few being implanted sensors. 133 products are either approved or in the development stage, according to the GlobalData pipeline products database. The research indicates that this market niche is expanding quickly and is a hub for innovative new technologies like implantable CGMs.Twelve percent of adult Americans report having taken a GLP-1 drug at some point, according to the most recent KFF Health Tracking poll. In the prev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-best-diabetes-141655970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVIW.SI","IE00B2B36J28.USD","TSYW.SI","CAGR","LU0109394709.USD","BK4023","BK4588",".IXIC","IE00B19Z3B42.SGD","LU1093756168.USD","LU2362540622.SGD","LU0889565916.HKD","LU2236285917.USD","VRTX","LU2324357040.USD","LU0061475181.USD","QID","MNQmain","LU1559883803.SGD","LU2362541273.HKD","USAW.SI","IE00BFTCPJ56.SGD","BK4567","IE0002270589.USD","LU1069344957.HKD","VERX","IE00B19Z3581.USD","LU0079474960.USD","LU2362541513.USD","SQQQ","IE00B19Z9P08.USD","CF","LU2462157665.USD","LU2237438978.USD","PSQ","BK4533","LU1035775433.USD","LU1093756325.SGD","USJW.SI","IE00B4R5TH58.HKD","LU0058720904.USD","QLD","LU0256863811.USD","IE00BJJMRZ35.SGD","LU0757428866.USD","TQQQ","NQmain","IE00BJT1NW94.SGD","LU0234570918.USD"],"gpt_icon":1},{"id":"2520415110","title":"Why You Shouldn't Bet Against CF Industries (CF) Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2520415110","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520415110?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 21:45","pubTimestamp":1742391900,"startTime":"0","endTime":"0","summary":"One stock that might be an intriguing choice for investors right now is CF Industries Holdings, Inc. CF. This is because this security in the Fertilizers space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Fertilizers space as it currently has a Zacks Industry Rank of 59 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.Meanwhile, CF Industries is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term.CF Industries Holdings, I","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-shouldnt-bet-against-cf-134500084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CF","BK4093","BK4588","BK4585"],"gpt_icon":0},{"id":"2520958959","title":"CF Industries Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2520958959","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520958959?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 05:16","pubTimestamp":1742332560,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of CF Industries Holdings Inc.  shed 1.71% to $76.40 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 1.07% to 5,614.66 and Dow Jones Industrial Average  falling 0.62% to 41,581.31.CF Industries Holdings Inc. closed 22.24% short of its 52-week high of $98.25, which the company achieved on January 16th.The stock underperformed when compared to some of its competitors Tuesday, as Mosaic Co.  rose 2.53% to $27.20 and Westlake Corp.  fell 1.70% to $105.86.Trading volume  remained 310,375 below its 50-day average volume of 2.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 18, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CF"],"gpt_icon":0},{"id":"2520643131","title":"Vertex Pharmaceuticals (VRTX): One of the Best Biotech Stocks to Buy According to Billionaires","url":"https://stock-news.laohu8.com/highlight/detail?id=2520643131","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520643131?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 17:26","pubTimestamp":1742289975,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated  stands against other best biotech stocks.Although biotech stocks had a “challenging” year in 2024, JPMorgan believes that some of the industry’s companies could see significant growth in the months to come. Senior partner and principal of investments at Novo Holdings, Johan Hueffer, spoke on CNBC on November 28 about his macro outlook for life sciences investments. He claimed that in the past few years, biotechs have had trouble raising funding. Over the past quarter or two, though, that tendency has begun to improve.Flood’s report also emphasized how the biotech sector has recently demonstrated better fundamentals, which have been ascribed to superior clinical outcomes and a more favorable regulatory environment. Goldman’s data shows that hedge funds continue to underinvest in biotechnology despite these ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vertex-pharmaceuticals-vrtx-one-best-092615738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4552","US10Y.BOND","NVIW.SI","BK4588","TQQQ","USAW.SI","QID","US30Y.BOND","QLD","LU2237443978.SGD","US6M.BOND","USJW.SI","LU0096364046.USD","LU2324357040.USD","BK4585","IE00BFXG1179.USD","SCD","VRTX","LU0417517546.SGD",".IXIC","US12M.BOND","US3Y.BOND","IE00BSNM7G36.USD","CF","BK4533","IE00BJJMRZ35.SGD","MNQmain","LU2462157665.USD","US7Y.BOND","LU2237443382.USD","LU0058720904.USD","BK4093","VERX","NQmain","LU2237443465.HKD","PSQ","US2Y.BOND","IE0004091025.USD","US5Y.BOND","LU2471134796.USD","LU1791807156.HKD","BK4504","LU2750360997.AUD","TSYW.SI","FOMC","SQQQ","LU2237443549.SGD","BK4567","LU2471134879.HKD"],"gpt_icon":1},{"id":"2520689131","title":"CF Industries Holdings Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2520689131","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520689131?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 05:15","pubTimestamp":1742246100,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of CF Industries Holdings Inc.  rallied 1.44% to $77.73 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.64% to 5,675.12 and the Dow Jones Industrial Average  rising 0.85% to 41,841.63.The stock's rise snapped a two-day losing streak.CF Industries Holdings Inc. closed 20.89% short of its 52-week high of $98.25, which the company reached on January 16th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Mosaic Co.  rose 2.43% to $26.53 and Westlake Corp.  rose 0.38% to $107.69.Trading volume  remained 691,558 below its 50-day average volume of 2.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 17, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CF"],"gpt_icon":0},{"id":"2520499572","title":"Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520499572","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520499572?lang=en_us&edition=full_marsco","pubTime":"2025-03-17 22:47","pubTimestamp":1742222820,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Incorporated VRTX stock has plunged 25.3% this year so far against the industry’s 5.4% increase.The stock’s price increase is mainly because the company gained approval for two new products, its novel non-opioid pain medicine Journavx  and its fifth cystic franchise  medicine Alyftrek, recently. Let us understand the company’s strengths and weaknesses to better analyze how to play the stock given the recent increase in price.Vertex holds a dominant position in the cystic franchise  market. Its CF sales continue to grow, driven by higher sales of Trikafta/Kaftrio in younger age groups. Vertex’s CF product revenues rose in the double-digit range for 10 consecutive years.Journavx , Vertex’s non-opioid NaV1.8 pain signal inhibitor, for the treatment of moderate-to-severe acute pain, was approved by the FDA in January 2025. At the fourth-qu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vertex-25-ytd-buy-sell-144700220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2417539215.USD","LU0061475181.USD","IE00B19Z3581.USD","LU2324357040.USD","BK4568","LU0757428866.USD","LU1861559042.SGD","LU2236285917.USD","IE0009355771.USD","LU0823416689.USD","BK4556","BK4551","BK4611","LU0058720904.USD","BK4534","IE00B19Z3B42.SGD","IE00B19Z9Z06.USD","VERX","LU2237438978.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","BK4567","LU2462157665.USD","BK4532","BK4501","LU1430594728.SGD","LU1585245621.USD","LU0079474960.USD","CRSP","IE00BZ9MQY76.HKD","BK4548","LU2456880835.USD","SCD","LU0320765992.SGD","BK4138","BK4023","CF","LU2362541273.HKD","LU1069344957.HKD","BK4093","LU2362541513.USD","IE00B19Z9P08.USD","LU2362540622.SGD","VRTX","VTNR","IE00B2B36J28.USD","LU0566484027.USD","IE00B894F039.SGD","LU1035775433.USD"],"gpt_icon":1},{"id":"2520092155","title":"CF Industries Holdings Insiders Sold US$899k Of Shares Suggesting Hesitancy","url":"https://stock-news.laohu8.com/highlight/detail?id=2520092155","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520092155?lang=en_us&edition=full_marsco","pubTime":"2025-03-17 21:30","pubTimestamp":1742218251,"startTime":"0","endTime":"0","summary":"In the last year, many CF Industries Holdings, Inc. ( NYSE:CF ) insiders sold a substantial stake in the company which...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2023000-choice1-main-header/1585186651478","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2023000-choice1-main-header/1585186651478"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-cf/cf-industries-holdings/news/cf-industries-holdings-insiders-sold-us899k-of-shares-sugges","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CF","BK4588","BK4585","BK4093"],"gpt_icon":0},{"id":"2519346994","title":"Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2519346994","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519346994?lang=en_us&edition=full_marsco","pubTime":"2025-03-16 04:43","pubTimestamp":1742071388,"startTime":"0","endTime":"0","summary":"We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where Sionna Therapeutics, Inc.  stands against other top insider purchases last month.How will new tariffs impact the U.S. economy?What’s next on President Trump’s geopolitical agenda?These are some of the concerning questions influencing market conditions.According to J.P. Morgan’s chief global economist, Bruce Kasman, there is about a 40% chance of a U.S. recession and a risk of lasting damage to the country’s reputation as an investment destination, writes Reuters.“Where we stand now is with a heightened concern about the U.S. economy,” Kasman said to reporters in Singapore on Wednesday.Additionally, Goldman Sachs lowered its 2025-end target for the broader market. “The proximate causes of the market decline are the jump in policy uncertainty largely related to tariffs, concerns about the economic growth outlook, and a positioning unwind, especially among hedge funds","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sionna-therapeutics-inc-sion-among-204308018.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0061475181.USD","BK4516","BK4127","BK4585","IE0004086264.USD","IE0002270589.USD","SION","BK4504","LU2471134523.USD","BK4552","BK4550","IE00BSNM7G36.USD","LU2237443382.USD","IE00B19Z3581.USD","LU1868836914.USD","LU2750360641.GBP","LU2237443895.HKD","LU1868836591.USD","LU2237443465.HKD","BK4139","LU2750360997.AUD","LU1868837136.USD","IE0004091025.USD","BK4588","CF","IE00B19Z3B42.SGD","LU2237438978.USD","LU2237443978.SGD","LU2471134796.USD","LU0106831901.USD","LU0096364046.USD","LU1868837300.USD","BK4533","LU2237443622.USD","LU2471134879.HKD","LU1791807156.HKD","LU2237443549.SGD","BK4093","LU1868836757.USD","LU1668664300.SGD","LU2471134952.CNY","IE00BFXG1179.USD","IE0034235188.USD"],"gpt_icon":0},{"id":"2519759738","title":"3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2519759738","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519759738?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 17:51","pubTimestamp":1741945860,"startTime":"0","endTime":"0","summary":"AbbVie is a Dividend King with an attractive valuation.Vertex Pharmaceuticals' growth should accelerate after two key FDA approvals.Kiniksa Pharmaceuticals arguably has a gold mine with its recurrent pericarditis drug Arcalyst.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/14/3-no-brainer-healthcare-stocks-to-buy-with-1000-ri/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4093","IE00B2B36J28.USD","HCSG","LU0109394709.USD","BK4023","IE00B19Z3B42.SGD","LU1093756168.USD","LU2362540622.SGD","LU1585245621.USD","IE00B894F039.SGD","LU0889565916.HKD","LU2236285917.USD","VRTX","LU2417539215.USD","LU2324357040.USD","LU0061475181.USD","IE0002141913.USD","LU0320765992.SGD","LU0566484027.USD","LU2362541273.HKD","BK4139","IE00BFTCPJ56.SGD","IE0002270589.USD","IE00BMG7P694.USD","IE00BD4GTW91.USD","VERX","LU0079474960.USD","PEG","LU2362541513.USD","BK4532","IE00BMG7P587.USD","LU2456880835.USD","IE00B19Z9P08.USD","CF","LU2462157665.USD","LU2237438978.USD","BK4533","IE00BD4GTT62.SGD","LU1093756325.SGD","IE00B4R5TH58.HKD","LU0058720904.USD","LU0256863811.USD","LU0289739699.SGD","LU0757428866.USD","BK4137","IE00BD4GTV84.USD","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","LU0234570918.USD","IE00BZ9MQY76.HKD"],"gpt_icon":0},{"id":"2519881596","title":"Director’s Bold Move: Major Investment in CF Bankshares!","url":"https://stock-news.laohu8.com/highlight/detail?id=2519881596","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519881596?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 10:10","pubTimestamp":1741918231,"startTime":"0","endTime":"0","summary":"New insider activity at CF Bankshares ( ($CFBK) ) has taken place on March 14, 2025. Director Robert Hoeweler has made a significant investment in ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/directors-bold-move-major-investment-in-cf-bankshares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/directors-bold-move-major-investment-in-cf-bankshares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CF","BK4093","BK4585","BK4588"],"gpt_icon":0},{"id":"2519857812","title":"Goldman Sachs starts coverage on agriculture chemical stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2519857812","media":"Investing.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519857812?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 01:06","pubTimestamp":1741885577,"startTime":"0","endTime":"0","summary":"Investing.com --Goldman Sachs initiated research coverage on U.S. agricultural input stocks, favoring defensive and value plays in a weakening agricultural macro environment. “We believe the ag macro is still in the process of settling lower from the peak caused by the Russia/Ukraine War,” analyst at Goldman Sachs said. The brokerage issued \"Buy\" ratings on Corteva , FMC Corp , and Mosaic, while assigning a \"Neutral\" rating to CF Industries  and a \"Sell\" rating to Nutrien .Goldman noted that the agricultural sector is still normalizing from the price surge caused by the Russia-Ukraine war, with corn, a key proxy, expected to stabilize in the $3-$4 per bushel range, similar to levels seen from 2014 to 2020. While a stronger-than-expected spring 2025 planting season could provide near-term support, the firm expects the downward trend to resume later in the year.Among agricultural inputs, seeds remain the most resilient business in a weaker commodity cycle, according to Goldman. The firm ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/goldman-sachs-starts-coverage-agriculture-170617178.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2237443382.USD","CTVA","BK4552","LU0471298777.SGD","LU0345781412.USD","LU0612318971.USD","CF","IE0002270589.USD","BK4533","LU2237443549.SGD","LU0612318385.USD","LU2471134796.USD","LU1506573853.SGD","LU1868837300.USD","LU1868836757.USD","LU1868836914.USD","LU1668664300.SGD","IE00B19Z3B42.SGD","LU0096364046.USD","LU2750360997.AUD","BK4516","IE00BFXG1179.USD","LU0654597011.USD","BK4585","IE0004091025.USD","BK4093","LU2237443895.HKD","IE00B19Z3581.USD","LU1430597077.USD","LU0345780950.USD","BK4535","BK4588","LU2237443465.HKD","LU0630314457.HKD","BK4545","FMC","GS","NTR","LU1868837136.USD","LU2237443622.USD","LU1868836591.USD","BK4504","IE00BSNM7G36.USD","LU0061475181.USD","LU0385154629.USD","LU2471134523.USD","LU1791807156.HKD","BK4550","LU2237438978.USD","IE0034235188.USD"],"gpt_icon":0},{"id":"2519885532","title":"CF Industries Initiated at Neutral by Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2519885532","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519885532?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 17:38","pubTimestamp":1741858680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CF/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 13, 2025 05:38 ET (09:38 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CF"],"gpt_icon":0},{"id":"2519002223","title":"CF Industries initiated with a Neutral at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2519002223","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519002223?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 16:35","pubTimestamp":1741854919,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of CF Industries (CF) with a Neutral rating and $86 price target implying 11% upside. CF is a pure-play nitrogen p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cf-industries-initiated-with-a-neutral-at-goldman-sachs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cf-industries-initiated-with-a-neutral-at-goldman-sachs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CF"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cfindustries.com","stockEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0112},{"period":"3month","weight":-0.0993},{"period":"6month","weight":-0.1051},{"period":"1year","weight":-0.0632},{"period":"ytd","weight":-0.1017}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0479},{"period":"3month","weight":-0.0545},{"period":"6month","weight":-0.005},{"period":"1year","weight":0.096},{"period":"ytd","weight":-0.0298}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"CF Industries Holdings, Inc. manufactures and sells hydrogen and nitrogen products for energy, fertilizer, emissions abatement, and other industrial activities worldwide. Its principal products include anhydrous ammonia, granular urea, urea ammonium nitrate, and ammonium nitrate products. The company also offers diesel exhaust fluid, urea liquor, nitric acid, and aqua ammonia products; and compound fertilizer products with nitrogen, phosphorus, and potassium. It primarily serves cooperatives, independent fertilizer distributors, traders, wholesalers, and industrial users. The company was founded in 1946 and is headquartered in Deerfield, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.024238},{"month":2,"riseRate":0.7,"avgChangeRate":0.060636},{"month":3,"riseRate":0.25,"avgChangeRate":-0.042749},{"month":4,"riseRate":0.631579,"avgChangeRate":0.018049},{"month":5,"riseRate":0.578947,"avgChangeRate":-0.047623},{"month":6,"riseRate":0.421053,"avgChangeRate":0.006911},{"month":7,"riseRate":0.842105,"avgChangeRate":0.063993},{"month":8,"riseRate":0.578947,"avgChangeRate":0.036127},{"month":9,"riseRate":0.65,"avgChangeRate":0.001582},{"month":10,"riseRate":0.45,"avgChangeRate":0.015258},{"month":11,"riseRate":0.65,"avgChangeRate":0.027108},{"month":12,"riseRate":0.7,"avgChangeRate":0.034502}],"exchange":"NYSE","name":"CF Industries Holdings Inc","nameEN":"CF Industries Holdings Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CF Industries Holdings Inc(CF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CF Industries Holdings Inc(CF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CF Industries Holdings Inc,CF,CF Industries Holdings Inc股票,CF Industries Holdings Inc股票老虎,CF Industries Holdings Inc股票老虎国际,CF Industries Holdings Inc行情,CF Industries Holdings Inc股票行情,CF Industries Holdings Inc股价,CF Industries Holdings Inc股市,CF Industries Holdings Inc股票价格,CF Industries Holdings Inc股票交易,CF Industries Holdings Inc股票购买,CF Industries Holdings Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CF Industries Holdings Inc(CF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CF Industries Holdings Inc(CF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction